NVS
Novartis AG · Healthcare · Drug Manufacturers - General
Momentum-Eingaben (vergleichbare Manager): Halterbreite 0.0% · Aktienfluss -0.8% · neue Nettopositionen 0.0% — Formel
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q3 2024
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 125 | +1 | 102.39M | $16.04B | +8 | −7 |
| Q1 2026 | 126 | +1 | 113.27M | $17.29B | +8 | −7 |
| Q4 2025 | 124 | +1 | 102.45M | $14.13B | +1 | — |
| Q3 2025 | 20 | -1 | 49.48M | $6.35B | — | −1 |
| Q2 2025 | 18 | 0 | 41.97M | $5.08B | +2 | −2 |
| Q1 2025 | 16 | +1 | 41.02M | $4.58B | +1 | — |
| Q4 2024 | 15 | +1 | 35.01M | $3.41B | +1 | — |
| Q3 2024 | 13 | 0 | 33.66M | $3.89B | — | — |
| Q2 2024 | 13 | — | 33.92M | $3.61B | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox ✦ | 12.22M | -0.1% | $1.41B | 0.8% | ▼ Trim | 2 | SEC ↗ |
| 2 | PRIMECAP Management ✦ | 12.01M | -1.4% | $1.38B | 1.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | Wellington Management ✦ | 4.00M | -8.8% | $459.99M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 4.00M | -8.8% | $459.99M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 5 | Wellington Management ✦ | 4.00M | -8.8% | $459.99M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 4.00M | -8.8% | $459.99M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 7 | Wellington Management ✦ | 4.00M | -8.8% | $459.99M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 4.00M | -8.8% | $459.99M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 9 | Wellington Management ✦ | 4.00M | -8.8% | $459.99M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 10 | Wellington Management ✦ | 4.00M | -8.8% | $459.99M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 11 | Renaissance Technologies ✦ | 2.30M | -8.0% | $264.62M | 0.4% | ▼ Trim | 2 | SEC ↗ |
| 12 | Fisher Asset Management ✦ | 1.71M | +15.7% | $196.23M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 13 | Arrowstreet Capital ✦ | 899.92K | +42.7% | $122.40M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 182.18K | -26.1% | $20.95M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 182.18K | -26.1% | $20.95M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 120.72K | +1603.4% | $13.89M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 120.72K | +1603.4% | $13.89M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | Tweedy, Browne ✦ | 85.35K | -2.6% | $9.82M | 0.5% | ▼ Trim | 2 | SEC ↗ |
| 19 | D. E. Shaw & Co. ✦ | 48.42K | +1607.5% | $5.57M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | Millennium Management ✦ | 40.19K | +353.5% | $4.62M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | Two Sigma Investments ✦ | 28.37K | -81.9% | $3.26M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 16.61K | +71.2% | $1.91M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 16.61K | +71.2% | $1.91M | 0.0% | ▲ Add | 2 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Keine neu erfassten Käufer in diesem Quartal. |
Ausgestiegen
| Keine erfassten Ausstiege in diesem Quartal. |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 2 Inhaber, 1.31M Anteile, $431.09M gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.